7:03 am RedHill Biopharma provides update on RHB-102 development and intellectual property; co has secured from Temple University direct rights to the original RHB-102 patents and has terminated its agreement with SCOLR Pharma
moreView todays social media effects on RDHLView the latest stocks trending across Twitter. Click to view dashboardSee who Redhill is hiring next, click here to view […]